Issue of Equity

RNS Number : 4009T
BB Healthcare Trust PLC
17 July 2020
 

17 July 2020

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM OR TO PROFESSIONAL INVESTORS IN IRELAND)


BB Healthcare Trust plc


Issue of Ordinary Shares


BB Healthcare Trust plc (the "Company") announces that it has today issued 700,000 of its ordinary shares of one penny each ("Ordinary Shares") pursuant to its block listing facility. The Ordinary Shares will be issued at a price of 168.03 pence per Ordinary Share, a premium to the prevailing net asset value ("cum income") per Ordinary Share.


Following the issue of Ordinary Shares, the Company's issued share capital will comprise (464,300,000) Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company. This figure (464,300,000) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


The Company's LEI is: 213800HQ3J3H9YF2UI82


For further information please contact:


Peel Hunt LLP

Liz Yong, Tom Pocock (Corporate Broking)

Telephone: +44 (0) 207 418 8900


J.P. Morgan Cazenove

James Bouverat (Sales)

Telephone: +44 (0) 207 134 2224


Bellevue Asset Management (UK) Ltd

Mark Ghahramani

Telephone: +44 (0) 203 326 2981

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFSEDLIDLII
UK 100

Latest directors dealings